Skip to content

1st SOHO Asia hopes to empower hematology community across Asia
FDA grants breakthrough designation to CAR-T therapy sofi-cel
Dr. Kelly Bolton on ivosidenib in IDH1-mutated CCUS
Talquetamab, teclistamab combo induces responses in patients with extramedullary myeloma
Dr. Manali Kamdar to give free virtual CAR-T talk at 4:30 pm CT on Jan. 20

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Rami Komrokji, MD

Cellular Therapy

Rami Komrokji, MD

Leukemia

Rami Komrokji, MD

Lymphoma

Rami Komrokji, MD

Multiple Myeloma

Rami Komrokji, MD

Myelodysplastic Syndromes

Rami Komrokji, MD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

January 25, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Rami Komrokji, MD

Rami-Komrokji

Rami Komrokji, MD

by Leah Sherwood
October 16, 2024
0 Comments
Less than a minute
260 Views
1 year ago

Share This Post:

Facebook Twitter Pinterest Whatsapp Cloud StumbleUpon Print Share via Email

Related Post

Dr. Hsin-An Hou

Ambassador Program, News, Society Updates

1st SOHO Asia hopes to empower hematology community across

January 24, 2026

pen check

Trending now, Leukemia, Acute Lymphoblastic Leukemia

FDA grants breakthrough designation to CAR-T therapy sofi-cel

January 21, 2026

SOHO Insider

ASH 2025, Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Video Interviews

Dr. Kelly Bolton on ivosidenib in IDH1-mutated CCUS

January 21, 2026

Time for Phase 2. Hand holds a cube with number '2'. Word 'Phase 2'. Beautiful black background. Business concept. Copy space.

Cellular Therapy, Multiple Myeloma

Talquetamab, teclistamab combo induces responses in patients with extramedullary

January 19, 2026

Expanding access to CAR-T

Community Oncology, Cellular Therapy, Video Interviews

Dr. Manali Kamdar to give free virtual CAR-T talk

January 17, 2026

FDA laptop

Multiple Myeloma, News

FDA clears IND for KLN-1010 in relapsed or refractory

January 17, 2026

Top Categories

Cellular Therapy

45

Leukemia

78

Lymphoma

80

Multiple Myeloma

72

Myelodysplastic Syndromes

27

Myeloproliferative Neoplasms

15

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Rami Komrokji, MD

Cellular Therapy

Rami Komrokji, MD

Leukemia

Rami Komrokji, MD

Lymphoma

Rami Komrokji, MD

Multiple Myeloma

Rami Komrokji, MD

Myelodysplastic Syndromes

Rami Komrokji, MD

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Dr. Hsin-An Hou

1st SOHO Asia hopes to empower hematology community across Asia

pen check

FDA grants breakthrough designation to CAR-T therapy sofi-cel

SOHO Insider

Dr. Kelly Bolton on ivosidenib in IDH1-mutated CCUS

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.